Last reviewed · How we verify
Hyperbaric Oxygen
At a glance
| Generic name | Hyperbaric Oxygen |
|---|---|
| Also known as | breathing 100% oxygen under hyperbaric circumstances, HBO, Hyperbaric Oxygen Preconditioning, HBOT, Hyperbaric oxygen therapy |
| Sponsor | Per Rotbøll Nielsen |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Hyperbaric Oxygen Therapy for Soft Tissue Sarcoma Pilot Study (PHASE4)
- Validation of the Use of the Arteriovenous Tension Difference in CO2 Under Hyperbaric Conditions
- Adjunctive Hyperbaric Oxygen Treatment for Patients With Necrotizing Soft-Tissue Infection (HOT-NSTI Trial). Investigator-initiated, International, Multicentre, Superiority, Randomized, Open-label, Clinical Trial. (PHASE4)
- Hyperbaric Oxygen Therapy for Post Traumatic Stress Disorder - a Pragmatic, Double Blinded Randomized Trial (NA)
- Improving Post COVID-19 Syndrome With Hyperbaric Oxygen Treatments (NA)
- Optimal Number of Hyperbaric Oxygen Treatments for Carbon Monoxide Poisoning (NA)
- Self-hangIng Patient and Hyperbaric Oxygen Therapy _ SIPHON Study (PHASE4)
- The Effect of Nitrogen Narcosis on Motor Performance in Divers Who Have Sustained an Inner Ear Decompression Illness
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |